THURSDAY, May 19, 2022 (HealthDay News) — Is an upcoming final exam or big-time job interview stressing you out? Hug your honey. That’s the takeaway from new research that showed how embracing your significant other can help calm women. But sorry, guys, the same isn’t true for you, according toContinue Reading
TUESDAY, May 17, 2022 (HealthDay News) — Certain common viruses, including the genital herpes virus, might contribute to the risk of type 2 diabetes, a new study hints. Type 2 diabetes is a highly prevalent disease, with older age and obesity being two of the major risk factors. Now theContinue Reading
TUESDAY, May 17, 2022 (HealthDay News) — Vaccination against the virus that causes most cervical cancers has spurred a widespread reduction of infections among young Americans — including those who are unvaccinated, a new government study finds. The study, by the U.S. Centers for Disease Control and Prevention, looked atContinue Reading
THURSDAY, May 12, 2022 (HealthDay News) — The first underwear meant to protect against sexually transmitted infections during oral sex was approved by the U.S. Food and Drug Administration on Thursday. Lorals — which are available as bikinis or shorties — are made of vanilla-flavored latex about as thin asContinue Reading
MONDAY, April 25, 2022 (HealthDay News) — Two in five adults with attention-deficit/hyperactivity disorder say their mental health is excellent, which is significantly lower than people without the disorder, but still an encouraging finding, according to the authors of a new study. Their analysis of a Canadian government mental healthContinue Reading
WEDNESDAY, April 13, 2022 (HealthDay News) — Rates of gonorrhea are on the rise, and this sexually transmitted disease is becoming increasingly resistant to antibiotics, raising fears of a potential superbug. Luckily, while there isn’t a vaccine against gonorrhea yet, an available meningitis vaccine may offer some protection against thisContinue Reading
WEDNESDAY, April 13, 2022 (HealthDay News) — The more orgasms you have, the more you come to expect. And the reverse is also true, according to a new study of the so-called orgasm gap — in which men climax far more often than their female partners. “Our expectations are shapedContinue Reading
TUESDAY, April 12, 2022 (HealthDay News) — Even as the COVID-19 pandemic kept people isolated at home, sexually transmitted disease (STDs) cases increased across the United States. Although cases fell in the pandemic’s early months, infections rose again by the end of 2020, with gonorrhea, syphilis and congenital syphilis surpassingContinue Reading
TUESDAY, April 12, 2022 (HealthDay News) — A single dose of human papillomavirus (HPV) vaccine provides as much protection against cervical cancer as the standard three-dose regimen, a new study finds. “These findings are a game-changer that may substantially reduce the incidence of HPV-attributable cervical cancer, and positions single-dose HPVContinue Reading
MONDAY, April 11, 2022 (HealthDay News) — Catching COVID-19 appears to increase an older person’s risk of developing a case of shingles. Researchers found that people 50 and older who had a COVID infection were 15% more likely to develop shingles, compared to people who were never infected. That riskContinue Reading
MONDAY, April 11, 2022 (HealthDay News) — Too few sexually active teens are getting tested for sexually transmitted diseases (STDs), according to a new report by U.S. health officials. In all, just 20% of sexually active high school students said they were tested for an STD — now called sexuallyContinue Reading
THURSDAY, April 7, 2022 (HealthDay News) — The introduction of HAART (highly active anti-retroviral therapy) in the mid-1990s revolutionized the treatment of HIV/AIDS, halting disease progression and dramatically extending lives. Now, a small new study suggests another potential use for one of the standard HAART medications: It halted disease progressionContinue Reading
MONDAY, March 28, 2022 (HealthDay News) — Certain antiviral drugs used to treat HIV may also guard against COVID-19 infection, a new study suggests. The researchers found that people with HIV who are on antiretroviral treatment (ART) with protease inhibitors may have a lower risk of COVID-19 infection. Protease inhibitorsContinue Reading
TUESDAY, March 8, 2022 (HealthDay News) — There are serious mental harms and high financial costs associated with so-called conversion therapy for LGBTQ people, researchers report. Conversion therapy attempts to make lesbian, gay, bisexual, transgender and queer people “straight.” Its safety and effectiveness has been discredited in multiple prior studies.Continue Reading